VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+12.8%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$237M
AUM Growth
-$4.18M
(-1.7%)
Cap. Flow
-$15.8M
Cap. Flow
% of AUM
-6.66%
Top 10 Holdings %
Top 10 Hldgs %
7.93%
Holding
416
New
61
Increased
247
Reduced
47
Closed
61
Top Buys
| 1 |
EOG Resources
EOG
|
$2.02M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
$1.99M |
| 3 |
ConocoPhillips
COP
|
$1.85M |
| 4 |
Imperial Oil
IMO
|
$1.8M |
| 5 |
Reliance Steel & Aluminium
RS
|
$1.76M |
Top Sells
| 1 |
Ryman Hospitality Properties
RHP
|
$2.57M |
| 2 |
Western Midstream Partners
WES
|
$2.52M |
| 3 |
INN
Summit Hotel Properties
INN
|
$2.43M |
| 4 |
Brookfield Renewable
BEPC
|
$2.38M |
| 5 |
Grupo Aeroportuario del Pacifico
PAC
|
$2.16M |
Sector Composition
| 1 | Healthcare | 30.46% |
| 2 | Real Estate | 18.03% |
| 3 | Energy | 13.68% |
| 4 | Materials | 11.34% |
| 5 | Utilities | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Hercules Capital
HTGC
$3.52B
| $415K | 0.18% |
25,879
-2,324
| -8% | -$37.3K |
|
|
AMTI
177
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $415K | 0.18% |
9,424
+161
| +2% | +$7.09K |
|
178
Bain Capital Specialty
BCSF
$1.02B
| $411K | 0.17% |
27,815
+613
| +2% | +$9.06K |
|
179
Golub Capital BDC
GBDC
$3.94B
| $407K | 0.17% |
27,848
+2,230
| +9% | +$32.6K |
|
180
MacroGenics
MGNX
$123M
| $403K | 0.17% |
12,648
+229
| +2% | +$7.3K |
|
181
Alector
ALEC
$285M
| $401K | 0.17% |
19,917
+354
| +2% | +$7.13K |
|
|
MCI
182
Barings Corporate Investors
MCI
$434M
| $401K | 0.17% |
28,762
+6,442
| +29% | +$89.8K |
|
183
Gladstone Capital
GLAD
$585M
| $400K | 0.17% |
20,183
-1,104
| -5% | -$21.9K |
|
184
Horizon Technology Finance
HRZN
$296M
| $398K | 0.17% |
27,690
+10,565
| +62% | +$152K |
|
185
Krystal Biotech
KRYS
$4.33B
| $397K | 0.17% |
5,151
+99
| +2% | +$7.63K |
|
186
Gladstone Investment Corp
GAIN
$540M
| $390K | 0.16% |
31,850
-5,991
| -16% | -$73.4K |
|
|
ADAP
187
Adaptimmune Therapeutics
ADAP
$13.5M
| $389K | 0.16% |
73,237
+1,283
| +2% | +$6.82K |
|
188
Sixth Street Specialty
TSLX
$2.33B
| $388K | 0.16% |
18,469
+937
| +5% | +$19.7K |
|
189
Precision BioSciences
DTIL
$59.3M
| $387K | 0.16% |
1,246
+21
| +2% | +$6.52K |
|
|
KRTX
190
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $383K | 0.16% |
3,186
+64
| +2% | +$7.69K |
|
|
IMAB
191
I-MAB
IMAB
$355M
| $381K | 0.16% |
7,860
+135
| +2% | +$6.54K |
|
192
Allogene Therapeutics
ALLO
$246M
| $378K | 0.16% |
10,721
+185
| +2% | +$6.52K |
|
|
FCT
193
First Trust Senior Floating Rate Income Fund II
FCT
$263M
| $372K | 0.16% |
30,322
+4,457
| +17% | +$54.7K |
|
194
Protagonist Therapeutics
PTGX
$3.71B
| $372K | 0.16% |
14,346
+244
| +2% | +$6.33K |
|
195
SLR Investment Corp
SLRC
$911M
| $371K | 0.16% |
20,910
+1,137
| +6% | +$20.2K |
|
|
NSL
196
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $371K | 0.16% |
66,211
+4,059
| +7% | +$22.7K |
|
|
GTHX
197
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $369K | 0.16% |
15,319
+264
| +2% | +$6.36K |
|
|
MTEM
198
DELISTED
Molecular Templates, Inc.
MTEM
| $369K | 0.16% |
1,950
+35
| +2% | +$6.62K |
|
199
BlackRock Debt Strategies Fund
DSU
$547M
| $368K | 0.16% |
33,423
+3,472
| +12% | +$38.2K |
|
200
Codexis
CDXS
$218M
| $365K | 0.15% |
15,949
+290
| +2% | +$6.64K |
|